• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国山东省淋病实验室诊断的可及性及其在病例报告中的意义

Availability of Laboratory Diagnosis of Gonorrhoea and Its Meaning in Case Reporting in Shandong Province, China.

作者信息

Chen Xinlong, Gan Yanling, Liu Dianchang

机构信息

Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610072, People's Republic of China.

Department of STI and Leprosy Prevention and Control, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250022, People's Republic of China.

出版信息

Clin Cosmet Investig Dermatol. 2023 Mar 31;16:783-791. doi: 10.2147/CCID.S402676. eCollection 2023.

DOI:10.2147/CCID.S402676
PMID:37025397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10072148/
Abstract

BACKGROUND

Gonorrhea, caused by the bacterium (NG), is a major public health concern worldwide.

AIM OF THE STUDY

The aim of this study is to understand the availability of laboratory diagnosis of gonorrhoea in Shandong province and its meaning in case reporting.

METHODS

Two surveys were conducted among hospitals providing clinical services for sexually transmitted infection (STI) in Shandong Province in 2012 and 2018. The availability of laboratory tests for and distribution of reported gonorrhea cases were compared among different hospitals provided clinical services for STI in Shandong province. Descriptive analysis and Chi-square were used for statistical analysis.

RESULTS

Smear, culture and PCR tests for NG were used among 301(74.69%), 123(30.52%), 43(10.67%) hospitals in 2012 and 356(74.48%), 176(36.82%) and 73(15.27%) hospitals in 2018, respectively. Significant differences were observed in the availability of smear among hospitals at different levels (X=12.159, p=0.000) and with different affiliations (X=4.551, p=0.033) in 2018. Significant differences were observed in the availability of culture and PCR tests among hospitals at different levels both in 2012 (X=34.532, p=0.000; X=7.380, p=0.007) and 2018 (X=49.820, p=0.000; X=21.658, p=0.000). The availability of culture and PCR tests for NG among hospitals in 2018 was higher than that in 2012 (X=3.870, p=0.049; X=4.050, p=0.044). More hospitals reported gonorrhea cases in 2018 than in 2012 (X=6.768, p=0.009). A significant difference was observed in distribution of case reporting among hospitals at different levels in 2018 (X=6.975, p=0.008) and among different types of hospital both in 2012 (X=52.362, p=0.000) and 2018 (X=74.478, p=0.000).

CONCLUSION

Poor availability of NG laboratory tests affects case reporting, and which is a crucial reason leading to underreporting of gonorrhea cases in Shandong province.

摘要

背景

由淋病奈瑟菌(NG)引起的淋病是全球主要的公共卫生问题。

研究目的

本研究旨在了解山东省淋病实验室诊断的可及性及其在病例报告中的意义。

方法

2012年和2018年对山东省提供性传播感染(STI)临床服务的医院进行了两次调查。比较了山东省不同提供STI临床服务的医院中NG实验室检测的可及性以及报告淋病病例的分布情况。采用描述性分析和卡方检验进行统计分析。

结果

2012年,301家(74.69%)、123家(30.52%)、43家(10.67%)医院分别采用了NG涂片、培养和PCR检测,2018年分别为356家(74.48%)、176家(36.82%)和73家(15.27%)医院。2018年,不同级别医院(X=12.159,p=0.000)和不同隶属关系医院(X=4.551,p=0.033)的涂片检测可及性存在显著差异。2012年(X=34.532,p=0.000;X=7.380,p=0.007)和2018年(X=49.820,p=0.000;X=21.658,p=0.000)不同级别医院的培养和PCR检测可及性均存在显著差异。2018年医院中NG培养和PCR检测的可及性高于2012年(X=3.870,p=0.049;X=4.050,p=0.044)。2018年报告淋病病例的医院比2012年多(X=6.768,p=0.009)。2018年不同级别医院(X=6.975,p=0.008)以及2012年(X=52.362,p=0.000)和2018年(X=74.478,p=0.000)不同类型医院的病例报告分布存在显著差异。

结论

NG实验室检测可及性差影响病例报告,这是导致山东省淋病病例报告不足的关键原因。

相似文献

1
Availability of Laboratory Diagnosis of Gonorrhoea and Its Meaning in Case Reporting in Shandong Province, China.中国山东省淋病实验室诊断的可及性及其在病例报告中的意义
Clin Cosmet Investig Dermatol. 2023 Mar 31;16:783-791. doi: 10.2147/CCID.S402676. eCollection 2023.
2
Disparity in Availability of Laboratory Testing for Syphilis Among Different Hospitals in Shandong Province, Eastern China.山东省不同医院梅毒实验室检测可及性的差异。
Asia Pac J Public Health. 2022 May;34(4):346-353. doi: 10.1177/10105395221078762. Epub 2022 Feb 15.
3
Availability of benzathine penicillin G for syphilis treatment in Shandong Province, Eastern China.中国东部山东省苄星青霉素G用于梅毒治疗的可及性。
BMC Health Serv Res. 2019 Mar 22;19(1):188. doi: 10.1186/s12913-019-4006-4.
4
Availability of Chlamydia trachomatis Testing and Its Importance in the Surveillance of Genital Chlamydial Infection.沙眼衣原体检测的可及性及其在生殖道沙眼衣原体感染监测中的重要性。
Jpn J Infect Dis. 2021 May 24;74(3):209-213. doi: 10.7883/yoken.JJID.2020.504. Epub 2020 Oct 30.
5
Rapid increase of gonorrhoea cases in Guangdong Province, China, 2014-2017: a review of surveillance data.中国广东省 2014-2017 年淋病病例的快速增长:监测数据回顾。
BMJ Open. 2019 Nov 10;9(11):e031578. doi: 10.1136/bmjopen-2019-031578.
6
Nonadherence to National Guidelines for Antibiotic Treatment of Uncomplicated Gonorrhea in China: Results From a Nationwide Survey.中国未遵循全国非复杂性淋病抗生素治疗指南:一项全国性调查的结果。
Sex Transm Dis. 2018 Sep;45(9):600-606. doi: 10.1097/OLQ.0000000000000819.
7
The Clinico-Epidemiological Profile of Patients with Gonorrhoea and Challenges in the Management of Neisseria gonorrhoeae Infection in an STI clinic, Ternopil, Ukraine (2013-2018).乌克兰捷尔诺波尔一家性传播感染诊所淋病患者的临床流行病学概况及淋病奈瑟菌感染管理面临的挑战(2013 - 2018年)
J Med Life. 2020 Jan-Mar;13(1):75-81. doi: 10.25122/jml-2019-0170.
8
Sexually transmitted infections in young pregnant women in Bangui, Central African Republic.中非共和国班吉年轻孕妇的性传播感染情况
Int J STD AIDS. 1999 Sep;10(9):609-14. doi: 10.1258/0956462991914753.
9
Prevalence of gonorrhoea and knowledge of sexually transmitted infections in a farming community in Zimbabwe.津巴布韦一个农业社区的淋病患病率及性传播感染知识
Cent Afr J Med. 1997 Jul;43(7):192-5.
10
A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study.不同性传播感染护理提供者对泌尿生殖系统、肛门直肠和口咽部淋病奈瑟菌检测与诊断的综合概述:一项横断面研究。
BMC Infect Dis. 2017 Apr 20;17(1):290. doi: 10.1186/s12879-017-2402-0.

本文引用的文献

1
Tolerance to Ceftriaxone in : Rapid Induction in WHO P Reference Strain and Detection in Clinical Isolates.头孢曲松的耐受性:世卫组织P参考菌株中的快速诱导及临床分离株中的检测
Antibiotics (Basel). 2022 Oct 26;11(11):1480. doi: 10.3390/antibiotics11111480.
2
Prevalence of reproductive tract infections among women preparing to conceive in Chongqing, China: trends and risk factors.中国重庆准备怀孕的妇女生殖道感染的流行情况:趋势和危险因素。
Reprod Health. 2022 Oct 3;19(1):197. doi: 10.1186/s12978-022-01502-x.
3
Development and comparison of predictive models for sexually transmitted diseases-AIDS, gonorrhea, and syphilis in China, 2011-2021.中国 2011-2021 年性传播疾病-艾滋病、淋病和梅毒预测模型的建立与比较。
Front Public Health. 2022 Aug 12;10:966813. doi: 10.3389/fpubh.2022.966813. eCollection 2022.
4
Sexually transmitted infections and female reproductive health.性传播感染与女性生殖健康。
Nat Microbiol. 2022 Aug;7(8):1116-1126. doi: 10.1038/s41564-022-01177-x. Epub 2022 Aug 2.
5
Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.泰国高水平青霉素耐药淋病奈瑟菌临床分离株的全基因组序列分析及药敏结果
PLoS One. 2022 Jul 29;17(7):e0271657. doi: 10.1371/journal.pone.0271657. eCollection 2022.
6
Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018.2018 年泰国曼谷淋病奈瑟菌分离株的基因组监测和抗菌药物耐药性。
J Antimicrob Chemother. 2022 Jul 28;77(8):2171-2182. doi: 10.1093/jac/dkac158.
7
Reliability of Genetic Alterations in Predicting Ceftriaxone Resistance in Neisseria gonorrhoeae Globally.全球淋病奈瑟菌中预测头孢曲松耐药性的遗传改变的可靠性。
Microbiol Spectr. 2022 Apr 27;10(2):e0206521. doi: 10.1128/spectrum.02065-21. Epub 2022 Mar 29.
8
Antimicrobial Susceptibility of Neisseria gonorrhoeae in Adult Patients Seeking Care at Military Hospitals in Thailand From 2014 to 2020.2014年至2020年泰国军队医院成年就诊患者中淋病奈瑟菌的抗菌药物敏感性
Mil Med. 2023 Jul 22;188(7-8). doi: 10.1093/milmed/usab549. Epub 2022 Jan 5.
9
Is it time to use nucleic acid amplification tests for identification of persons with sexually transmitted infections?: evidence from seroprevalence and behavioral epidemiology risk surveys in men with chlamydia and gonorrhea.是否到了使用核酸扩增检测来识别性传播感染患者的时候了?:来自衣原体和淋病男性患者血清流行率和行为流行病学风险调查的证据。
Pan Afr Med J. 2020 Aug 18;36:299. doi: 10.11604/pamj.2020.36.299.20777. eCollection 2020.
10
A Comparison of US Clinical Laboratory Chlamydia and Gonorrhea Testing Practices Before and After the 2014 Centers for Disease Control and Prevention Testing Recommendations.《2014 年美国疾病控制与预防中心检测建议前后美国临床实验室衣原体和淋病检测实践比较》
Sex Transm Dis. 2021 Jun 1;48(6):e73-e76. doi: 10.1097/OLQ.0000000000001299.